L3- Antidepressants (SARIs, SNRIs, SSRIs) Flashcards
list the SSRIs
(selective serotonin reuptake inhibitors) citalopram escitalopram fluoxetine fluvoxamine paroxetine sertraline
SSRI MOA
blocks SERT to inc 5-HT in synaptic cleft
list some of the AEs of SSRIs (due to inc serotonergic activity)
nausea, GI upset, diarrhea (gut)
diminished sexual function and interest (spinal cord)
weight gain (not as common as above AEs)
describe the dangerous drug interactions of SSRIs in general
serotonin syndrome if combined with MAOI or another serotonergic drug
describe the drug interactions of SSRIs by specific drugs
Fluoxetine, Paroxetine: CYP2D6 inhibitor –> high potential for drug interactions
Fluvoamine: CYP1A2, CYP2C19, CYP3A4 –> high potential
Citalopram, Escitalopram, Sertraline –> low potential
describe the result of SSRI overdose
seizures- low potential for fatality
list the SARIs
(5-HT2 antagonist / reuptake inhibitors)
- nefazodone
- trazodone
SARI MOA
- inhibits SERT / reuptake –> inc synaptic [5-HT] [weak activity]
- blocks 5-HT2 receptor –> to prevent stimulation and the anxiety and sexual dysfunction AEs [potent activity]
=> stimulation of 5-HT1A receptors (+ all other 5-HTRs)
nefazodone uses
- not really prescribed
- causes hepatotoxicity
trazodone:
- (1) additional mechanisms
- (2) are the main effects
1- α1 and H1 antagonist
2- sedation, hypnotic
trazodone:
- (1) main use
- (2) rare AE
1- hypnotic
2- priapism
list the SNRIs
(serotonin and NE reuptake inhibitors)
- venalfaxine
- duloxetine
SNRIs:
- (1) is main MOA
- importantly lacks (2) activity, to differentiate it from TCAs
1- blocks SERT, NET
2- α1, H1, mACh receptor blockade
discuss the difference in activities of venalfaxine and duloxetine
Duloxetine: inhibits SERT, NET at all doses
Venalfaxine:
- low doses, inhibits SERT»_space; NET (more potent for SERT)
- high doses, inhibits SERT and NET
- weak inhibition of Dopa reuptake
what is the key difference in terms of AEs with SNRIs vs SSRIs
much fewer CYP450 interactions